These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 22057933

  • 61. New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.
    Rastogi A, Arman F, Alipourfetrati S.
    Curr Hypertens Rep; 2016 Jul; 18(7):55. PubMed ID: 27230070
    [Abstract] [Full Text] [Related]

  • 62. Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease.
    Gupta G, Dahiya R, Singh Y, Mishra A, Verma A, Gothwal SK, Aljabali AAA, Dureja H, Prasher P, Negi P, Kapoor DN, Goyal R, Tambuwala MM, Chellappan DK, Dua K.
    Chem Biol Interact; 2020 Feb 01; 317():108975. PubMed ID: 32032593
    [Abstract] [Full Text] [Related]

  • 63. Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3-4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study.
    Rowan CG, Agiro A, Chan KA, Colman E, White K, Desai P, Dwyer JP.
    Adv Ther; 2024 Jun 01; 41(6):2381-2398. PubMed ID: 38687454
    [Abstract] [Full Text] [Related]

  • 64. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.
    Morales E, Gutiérrez E, Caro J, Sevillano A, Rojas-Rivera J, Praga M.
    Nefrologia; 2015 Jun 01; 35(6):554-61. PubMed ID: 26519114
    [Abstract] [Full Text] [Related]

  • 65. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease.
    Bermejo S, García CO, Rodríguez E, Barrios C, Otero S, Mojal S, Pascual J, Soler MJ.
    Nefrologia (Engl Ed); 2018 Jun 01; 38(2):197-206. PubMed ID: 29102270
    [Abstract] [Full Text] [Related]

  • 66. Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Johnson M, Morrison FJ, McMahon G, Su M, Turchin A.
    Am Heart J; 2023 Apr 01; 258():49-59. PubMed ID: 36642227
    [Abstract] [Full Text] [Related]

  • 67. Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
    Agiro A, An A, Cook EE, Mu F, Chen J, Desai P, Oluwatosin Y, Pollack CV.
    Adv Ther; 2023 Jun 01; 40(6):2886-2901. PubMed ID: 37140706
    [Abstract] [Full Text] [Related]

  • 68. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M, Shea A, Giguère P, Nguyen ML.
    Ann Pharmacother; 2016 Jun 01; 50(6):455-62. PubMed ID: 27048188
    [Abstract] [Full Text] [Related]

  • 69. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.
    Little DJ, Nee R, Abbott KC, Watson MA, Yuan CM.
    Clin Nephrol; 2014 Apr 01; 81(4):259-68. PubMed ID: 24656316
    [Abstract] [Full Text] [Related]

  • 70. Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
    Adelborg K, Nicolaisen SK, Hasvold P, Palaka E, Pedersen L, Thomsen RW.
    PLoS One; 2019 Apr 01; 14(6):e0218739. PubMed ID: 31226134
    [Abstract] [Full Text] [Related]

  • 71. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.
    Eur J Prev Cardiol; 2014 Mar 01; 21(3):299-309. PubMed ID: 24191305
    [Abstract] [Full Text] [Related]

  • 72. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.
    Nistor I, De Sutter J, Drechsler C, Goldsmith D, Soler MJ, Tomson C, Wiecek A, Donciu MD, Bolignano D, Van Biesen W, Covic A.
    Nephrol Dial Transplant; 2018 Jan 01; 33(1):12-22. PubMed ID: 29106631
    [Abstract] [Full Text] [Related]

  • 73. Hyperkalemia in the Hypertensive Patient.
    Lakkis JI, Weir MR.
    Curr Cardiol Rep; 2018 Mar 01; 20(2):12. PubMed ID: 29492706
    [Abstract] [Full Text] [Related]

  • 74. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
    Mewton N, Girerd N, Boffa JJ, Courivaud C, Isnard R, Juillard L, Lamblin N, Legrand M, Logeart D, Mariat C, Meune E, Sabouret P, Sebbag L, Rossignol P.
    Arch Cardiovasc Dis; 2020 Oct 01; 113(10):660-670. PubMed ID: 32660835
    [Abstract] [Full Text] [Related]

  • 75. Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
    Gilligan S, Raphael KL.
    Adv Chronic Kidney Dis; 2017 Sep 01; 24(5):315-318. PubMed ID: 29031358
    [Abstract] [Full Text] [Related]

  • 76. Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi Arabia.
    Shaheen FAM, Meunier A, Altowaijri A, Faadhel TA, Al-Abdulkarim H, AlGabash A, Floros L.
    Saudi J Kidney Dis Transpl; 2022 Feb 01; 33(Supplement):S39-S52. PubMed ID: 37102523
    [Abstract] [Full Text] [Related]

  • 77. Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension.
    Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR.
    Am J Kidney Dis; 2017 Dec 01; 70(6):844-858. PubMed ID: 29029808
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.